3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
40
Colorectal Neoplasms
24
Carcinoma, Non-Small-Cell Lung
18
Rectal Neoplasms
14
Lung Neoplasms
13
Stomach Neoplasms
12
Esophageal Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
9
Esophageal Squamous Cell Carcinoma
9
Prostatic Neoplasms
8
Pancreatic Neoplasms
8
Neoplasm Metastasis
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Adenocarcinoma Of Esophagus
8
Ovarian Neoplasms
7
Sarcoma
6
Neoplasms
6
Head and Neck Neoplasms
6
Urinary Bladder Neoplasms
5
Osteosarcoma
5
Liver Neoplasms
5
Kidney Neoplasms
4
Inflammatory Breast Neoplasms
4
Fallopian Tube Neoplasms
4
Carcinoma, Renal Cell
4
Breast Neoplasms, Male
4
Turcot syndrome
3
Multiple Myeloma
3
Locally Advanced Rectal Cancer
3
Interventions
atezolizumab
2
Sorafenib
2
Bevacizumab
2
titanium silicide
1
ledipasvir, sofosbuvir drug combination
1
halofantrine
1
genexol-PM
1
durvalumab
1
avatrombopag
1
aumolertinib
1
Sunitinib
1
Ramucirumab
1
Neoadjuvant Therapy
1
N-monoacetylcystine
1
Leucovorin
1
Injections
1
Immunotherapy
1
Formyltetrahydrofolates
1
Everolimus
1
Cisplatin
1
Catheter Ablation
1
Adjuvants, Pharmaceutic
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Liver Diseases
×
Neoadjuvant Therapy
×
Clear all
NCT04727307
2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2
Recruiting
202 enrolled